This topic contains a solution. Click here to go to the answer

Author Question: According to Eagly and her colleagues in the 2003 study, what is the likely reason why female ... (Read 126 times)

segrsyd

  • Hero Member
  • *****
  • Posts: 530
According to Eagly and her colleagues in the 2003 study, what is the likely reason why female leaders are more transformational than male leaders?
 
  a. men are more supportive of their followers
  b. women are more task-oriented
  c. women are more directive
  d. women show more individual attention to followers

Question 2

Sheryl Sandberg, COO of Facebook, believes that one cause of gender equality is:
 
  a. a lack of role models.
  b. discrimination by top management teams.
  c. imbalance in family responsibilities.
  d. lack of drive.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

missalyssa26

  • Sr. Member
  • ****
  • Posts: 327
Answer to Question 1

d

Answer to Question 2

c




segrsyd

  • Member
  • Posts: 530
Reply 2 on: Jul 7, 2018
Thanks for the timely response, appreciate it


isabelt_18

  • Member
  • Posts: 342
Reply 3 on: Yesterday
Gracias!

 

Did you know?

More than 34,000 trademarked medication names and more than 10,000 generic medication names are in use in the United States.

Did you know?

About 3.2 billion people, nearly half the world population, are at risk for malaria. In 2015, there are about 214 million malaria cases and an estimated 438,000 malaria deaths.

Did you know?

Oliver Wendell Holmes is credited with introducing the words "anesthesia" and "anesthetic" into the English language in 1846.

Did you know?

Coca-Cola originally used coca leaves and caffeine from the African kola nut. It was advertised as a therapeutic agent and "pickerupper." Eventually, its formulation was changed, and the coca leaves were removed because of the effects of regulation on cocaine-related products.

Did you know?

For high blood pressure (hypertension), a new class of drug, called a vasopeptidase blocker (inhibitor), has been developed. It decreases blood pressure by simultaneously dilating the peripheral arteries and increasing the body's loss of salt.

For a complete list of videos, visit our video library